Atlas Trials

Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for Warts

Clinical trial NCT05326152 · COMPLETED

Trial details

NCT number
NCT05326152
Sponsor
Zagazig University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Intralesional Versus Intramuscular Hepatitis B Vaccine for Multiple Common Warts
Start date
2020-11-25
Primary completion
2021-06-20
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.